Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolism
Stephen Jun Fei Chong(Harvard University), Shazib Pervaiz(National University of Singapore), Mary C. Collins(Dana-Farber Cancer Institute), Jianhua Qu, Charles Herbaux(Centre Hospitalier Universitaire de Lille), Deepika Raman(National University of Singapore), Ivan Cherh Chiet Low(National University of Singapore), Matthew S. Davids(Dana-Farber Cancer Institute), Thomas Kwok Seng Loh(National University Health System), Rebecca Valentin(Dana-Farber Cancer Institute), Kartini Iskandar(National University of Singapore), Jolin Xiao Hui Lai(National University of Singapore)
Cited by 63
Related Papers
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
|Journal of Clinical Oncology|2017|752
Small molecules, big impact: 20 years of targeted therapy in oncology
|The Lancet|2020|606
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
|New England Journal of Medicine|2016|595